Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
 Back to Profile

Marco Del Chiaro

Concepts (577)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Pancreatic Neoplasms
165
2025
938
32.170
 Why?
Pancreatectomy
71
2025
253
17.600
 Why?
Carcinoma, Pancreatic Ductal
68
2025
289
16.640
 Why?
Pancreaticoduodenectomy
33
2025
164
7.030
 Why?
Adenocarcinoma
29
2025
940
6.310
 Why?
Neoadjuvant Therapy
29
2025
404
5.470
 Why?
Pancreas
38
2024
329
4.290
 Why?
Mesenteric Veins
9
2025
24
4.180
 Why?
Adenocarcinoma, Mucinous
16
2024
80
3.760
 Why?
Portal Vein
13
2025
120
3.230
 Why?
Pancreatic Cyst
11
2024
60
2.700
 Why?
Antineoplastic Combined Chemotherapy Protocols
18
2025
1692
2.360
 Why?
Pancreatic Fistula
11
2023
30
2.220
 Why?
Ampulla of Vater
7
2025
42
2.100
 Why?
Common Bile Duct Neoplasms
6
2025
30
2.050
 Why?
Carcinoma, Papillary
9
2021
81
1.980
 Why?
Retrospective Studies
90
2025
15657
1.860
 Why?
Pancreatic Ducts
10
2022
85
1.830
 Why?
Humans
242
2025
137585
1.820
 Why?
CA-19-9 Antigen
4
2024
22
1.750
 Why?
Aged
88
2025
23961
1.700
 Why?
Survival Rate
23
2025
1972
1.650
 Why?
Exocrine Pancreatic Insufficiency
5
2019
21
1.600
 Why?
Postoperative Complications
31
2025
2654
1.560
 Why?
Prognosis
30
2025
4030
1.560
 Why?
Vascular Surgical Procedures
5
2025
303
1.510
 Why?
Middle Aged
95
2025
33479
1.440
 Why?
Early Detection of Cancer
6
2021
447
1.430
 Why?
Gastrointestinal Neoplasms
2
2023
77
1.390
 Why?
Neoplasm Recurrence, Local
6
2024
1079
1.350
 Why?
Mesenteric Artery, Superior
4
2020
17
1.310
 Why?
Pancreas Transplantation
24
2010
75
1.310
 Why?
Aged, 80 and over
44
2025
7635
1.230
 Why?
Male
112
2025
67762
1.190
 Why?
Pancreatitis, Chronic
6
2020
58
1.140
 Why?
Female
108
2025
73304
1.070
 Why?
Treatment Outcome
40
2025
10811
1.050
 Why?
Quality of Life
8
2025
2892
1.030
 Why?
Islets of Langerhans
5
2020
803
0.990
 Why?
Chemotherapy, Adjuvant
13
2025
389
0.980
 Why?
Carcinoma, Neuroendocrine
2
2023
42
0.970
 Why?
Endosonography
5
2021
156
0.960
 Why?
Nomograms
3
2022
54
0.910
 Why?
Precancerous Conditions
3
2015
169
0.910
 Why?
Adult
72
2025
37929
0.910
 Why?
Databases, Factual
3
2024
1357
0.900
 Why?
Biomarkers, Tumor
13
2024
1276
0.900
 Why?
Liver Neoplasms
4
2024
786
0.890
 Why?
Hepatoblastoma
1
2024
46
0.860
 Why?
Follow-Up Studies
23
2024
5131
0.860
 Why?
Duodenal Neoplasms
3
2023
23
0.850
 Why?
Neoplasms, Cystic, Mucinous, and Serous
3
2023
27
0.850
 Why?
Thrombelastography
2
2024
154
0.840
 Why?
Minimally Invasive Surgical Procedures
3
2020
179
0.770
 Why?
Fluorouracil
11
2025
208
0.750
 Why?
Leucovorin
8
2025
81
0.720
 Why?
Neoplasm Invasiveness
8
2025
510
0.710
 Why?
Surgical Stapling
1
2021
15
0.710
 Why?
Risk Assessment
11
2025
3457
0.700
 Why?
Absorbable Implants
1
2021
35
0.700
 Why?
Angiotensin-Converting Enzyme Inhibitors
1
2022
201
0.690
 Why?
Cystadenocarcinoma, Mucinous
2
2018
13
0.680
 Why?
Organ Transplantation
2
2023
250
0.680
 Why?
Neoplasm Staging
12
2024
1389
0.660
 Why?
Neoplasms, Second Primary
2
2019
118
0.660
 Why?
Sweden
6
2025
101
0.660
 Why?
Vascular Neoplasms
1
2020
18
0.650
 Why?
Neoplasms, Multiple Primary
3
2015
57
0.650
 Why?
Arteries
2
2019
269
0.640
 Why?
Deoxycytidine
9
2025
179
0.640
 Why?
Pancreatitis
5
2022
134
0.630
 Why?
Adenocarcinoma, Papillary
2
2017
12
0.630
 Why?
Endocrine System Diseases
1
2019
35
0.620
 Why?
Liver Transplantation
4
2024
871
0.620
 Why?
Practice Guidelines as Topic
4
2024
1587
0.610
 Why?
Neuroendocrine Tumors
4
2023
116
0.590
 Why?
Neoplasm Metastasis
2
2025
658
0.560
 Why?
Cohort Studies
12
2024
5742
0.560
 Why?
Patient Compliance
1
2021
581
0.540
 Why?
Europe
8
2021
414
0.540
 Why?
Evidence-Based Medicine
5
2024
740
0.530
 Why?
Metabolomics
2
2019
678
0.530
 Why?
Patient Selection
9
2024
696
0.520
 Why?
Living Donors
3
2016
295
0.520
 Why?
Kidney Transplantation
17
2016
708
0.510
 Why?
Hepatic Artery
4
2020
62
0.510
 Why?
Celiac Artery
4
2020
17
0.510
 Why?
Watchful Waiting
1
2016
81
0.500
 Why?
Pancreaticojejunostomy
3
2022
8
0.500
 Why?
Hepatitis B virus
1
2016
40
0.490
 Why?
Hypothermia, Induced
1
2016
80
0.480
 Why?
Prospective Studies
15
2024
7604
0.470
 Why?
Organ Sparing Treatments
1
2015
34
0.460
 Why?
Survival Analysis
12
2024
1325
0.450
 Why?
Pancreatic Diseases
3
2020
72
0.450
 Why?
Disease Progression
5
2022
2757
0.450
 Why?
Adenoma
3
2025
230
0.430
 Why?
Antineoplastic Agents
6
2021
2129
0.420
 Why?
Clinical Trials as Topic
1
2018
1050
0.420
 Why?
Japan
5
2025
115
0.420
 Why?
Radiotherapy, Adjuvant
2
2024
220
0.420
 Why?
Risk Factors
16
2024
10388
0.410
 Why?
Cholangiopancreatography, Endoscopic Retrograde
4
2019
213
0.410
 Why?
Cystadenocarcinoma
1
2013
4
0.410
 Why?
Cystadenoma
1
2013
6
0.410
 Why?
Combined Modality Therapy
5
2024
1236
0.410
 Why?
Palliative Care
3
2019
758
0.410
 Why?
Robotics
1
2014
94
0.400
 Why?
Carcinoma, Hepatocellular
1
2016
362
0.390
 Why?
Italy
11
2013
110
0.390
 Why?
Stomach Neoplasms
2
2024
122
0.380
 Why?
Cystadenoma, Serous
3
2020
21
0.380
 Why?
Autoimmune Diseases
3
2021
460
0.380
 Why?
Diabetes Mellitus
3
2019
1040
0.380
 Why?
Tomography, X-Ray Computed
10
2021
2691
0.380
 Why?
Incidence
8
2019
2804
0.370
 Why?
Diagnosis, Differential
8
2022
1483
0.370
 Why?
Peritoneal Neoplasms
2
2024
93
0.370
 Why?
Dilatation, Pathologic
3
2020
62
0.360
 Why?
Propensity Score
3
2025
294
0.350
 Why?
Gastroenterology
2
2023
180
0.350
 Why?
Risk
5
2022
912
0.340
 Why?
Gamma Rays
2
2021
57
0.340
 Why?
Magnetic Resonance Imaging
8
2021
3566
0.330
 Why?
Portal System
6
2020
14
0.330
 Why?
Chemoradiotherapy
2
2022
225
0.320
 Why?
Neoplastic Syndromes, Hereditary
1
2010
44
0.320
 Why?
Microbiota
3
2025
762
0.320
 Why?
Neoplasm Grading
4
2020
307
0.320
 Why?
Tissue Donors
14
2005
425
0.320
 Why?
Adolescent
15
2022
21513
0.310
 Why?
Decision Making
1
2016
900
0.310
 Why?
Kidney
2
2016
1468
0.300
 Why?
Lymphatic Metastasis
3
2024
352
0.300
 Why?
Age Factors
6
2022
3295
0.290
 Why?
Benchmarking
2
2020
186
0.290
 Why?
Population Surveillance
2
2019
482
0.290
 Why?
Young Adult
11
2022
13209
0.290
 Why?
Tumor Burden
2
2022
309
0.290
 Why?
Mass Screening
2
2019
1287
0.280
 Why?
Software
2
2017
665
0.280
 Why?
Graft Survival
12
2005
535
0.270
 Why?
Predictive Value of Tests
5
2024
2031
0.270
 Why?
Laparoscopy
3
2021
466
0.270
 Why?
Islets of Langerhans Transplantation
3
2020
64
0.270
 Why?
Genetic Predisposition to Disease
6
2019
2426
0.260
 Why?
Internationality
4
2020
155
0.260
 Why?
Cytoreduction Surgical Procedures
2
2024
63
0.260
 Why?
Disease-Free Survival
5
2023
686
0.260
 Why?
Family Health
1
2007
196
0.260
 Why?
Drainage
10
2022
173
0.250
 Why?
Pedigree
3
2014
514
0.250
 Why?
Multidetector Computed Tomography
2
2016
39
0.250
 Why?
Observer Variation
2
2024
343
0.240
 Why?
Cyst Fluid
2
2022
25
0.240
 Why?
Length of Stay
5
2021
1215
0.240
 Why?
Immunohistochemistry
5
2019
1738
0.240
 Why?
Lymphocytes, Tumor-Infiltrating
2
2018
210
0.230
 Why?
Cholangiocarcinoma
2
2024
104
0.230
 Why?
Proportional Hazards Models
4
2023
1266
0.230
 Why?
Mucosal-Associated Invariant T Cells
1
2025
37
0.230
 Why?
Pylorus
1
2024
18
0.230
 Why?
Chemoradiotherapy, Adjuvant
3
2019
43
0.220
 Why?
Gallbladder Neoplasms
1
2024
23
0.220
 Why?
Spheroids, Cellular
1
2025
76
0.220
 Why?
Perioperative Care
2
2024
178
0.220
 Why?
Time Factors
10
2021
6828
0.220
 Why?
Practice Patterns, Physicians'
2
2025
1313
0.210
 Why?
Prevalence
3
2023
2734
0.210
 Why?
Lymph Node Excision
1
2024
171
0.210
 Why?
Metastasectomy
1
2023
20
0.200
 Why?
Incidental Findings
2
2021
87
0.200
 Why?
Hyperemia
1
2023
49
0.200
 Why?
Hospital Mortality
4
2020
911
0.200
 Why?
Bile Duct Neoplasms
1
2024
124
0.200
 Why?
Reoperation
7
2018
573
0.200
 Why?
Pilot Projects
5
2023
1710
0.200
 Why?
Venous Thrombosis
1
2025
190
0.200
 Why?
Surgical Oncology
1
2022
27
0.190
 Why?
Hyperamylasemia
1
2022
4
0.190
 Why?
STAT3 Transcription Factor
2
2022
206
0.190
 Why?
Pancreatitis, Acute Necrotizing
1
2022
13
0.190
 Why?
Plastics
1
2022
42
0.190
 Why?
Forecasting
1
2023
389
0.190
 Why?
Carcinoma, Acinar Cell
1
2021
4
0.190
 Why?
Colonic Neoplasms
1
2024
258
0.180
 Why?
Angiotensin Receptor Antagonists
1
2022
92
0.180
 Why?
Biliary Tract Surgical Procedures
1
2021
26
0.180
 Why?
Multicenter Studies as Topic
1
2023
310
0.180
 Why?
Pathology, Clinical
1
2021
36
0.180
 Why?
Datasets as Topic
1
2021
121
0.180
 Why?
Cysts
1
2022
113
0.180
 Why?
ADAM10 Protein
1
2021
30
0.170
 Why?
Surgical Mesh
1
2021
47
0.170
 Why?
Fusobacterium nucleatum
1
2020
4
0.170
 Why?
Bacteria
2
2025
858
0.170
 Why?
Fusobacterium Infections
1
2020
7
0.170
 Why?
Surgeons
1
2025
297
0.170
 Why?
Netherlands
3
2025
88
0.170
 Why?
Amyloid Precursor Protein Secretases
1
2021
80
0.170
 Why?
Digestive System Surgical Procedures
1
2021
106
0.170
 Why?
Body Composition
1
2024
684
0.170
 Why?
Albumins
3
2025
114
0.170
 Why?
Microdissection
2
2011
15
0.170
 Why?
Oligonucleotides, Antisense
1
2020
112
0.170
 Why?
Antimetabolites, Antineoplastic
2
2010
94
0.160
 Why?
Blood
1
2020
107
0.160
 Why?
Child, Preschool
4
2024
11074
0.160
 Why?
Myeloid-Derived Suppressor Cells
1
2020
66
0.160
 Why?
Antibodies, Bacterial
1
2020
146
0.160
 Why?
Conservative Treatment
1
2020
33
0.160
 Why?
Paclitaxel
3
2025
230
0.160
 Why?
Radiation Injuries
1
2021
145
0.160
 Why?
Comorbidity
2
2022
1622
0.160
 Why?
Cyclosporine
4
2005
268
0.160
 Why?
Cystadenocarcinoma, Serous
1
2020
77
0.160
 Why?
Lasers
2
2011
130
0.160
 Why?
Dilatation
1
2019
67
0.160
 Why?
Elective Surgical Procedures
1
2020
179
0.150
 Why?
Biliary Tract Diseases
1
2019
39
0.150
 Why?
Epithelial-Mesenchymal Transition
1
2021
209
0.150
 Why?
Laparotomy
2
2016
109
0.150
 Why?
Bacterial Infections
1
2021
250
0.150
 Why?
Bile Ducts
1
2019
71
0.150
 Why?
Mouth
1
2019
87
0.150
 Why?
Organ Culture Techniques
1
2019
156
0.150
 Why?
Saliva
1
2020
242
0.150
 Why?
Sensitivity and Specificity
2
2021
1946
0.150
 Why?
Patient Care Team
3
2020
631
0.150
 Why?
Immunosuppressive Agents
6
2005
890
0.150
 Why?
Referral and Consultation
1
2024
786
0.150
 Why?
Nutritional Support
1
2018
34
0.150
 Why?
Gene Expression Regulation, Neoplastic
4
2019
1396
0.140
 Why?
Iopamidol
2
2016
17
0.140
 Why?
Fibrosis
1
2021
552
0.140
 Why?
Insulin
8
2013
2409
0.140
 Why?
DNA Damage
1
2021
420
0.140
 Why?
Recombinant Fusion Proteins
4
2005
665
0.140
 Why?
Societies, Medical
2
2020
820
0.140
 Why?
Jejunum
2
2016
31
0.140
 Why?
Patient Acceptance of Health Care
1
2024
806
0.140
 Why?
Carcinoma
1
2019
240
0.140
 Why?
DNA, Bacterial
1
2019
337
0.140
 Why?
Kaplan-Meier Estimate
2
2016
889
0.140
 Why?
Surveys and Questionnaires
5
2025
5778
0.140
 Why?
Radiosurgery
1
2020
344
0.140
 Why?
Logistic Models
2
2020
2074
0.140
 Why?
Malnutrition
1
2018
83
0.130
 Why?
Cross-Sectional Studies
3
2024
5472
0.130
 Why?
Biliary Tract Neoplasms
1
2016
30
0.130
 Why?
Hepatic Duct, Common
1
2016
6
0.130
 Why?
Jaundice, Obstructive
1
2016
3
0.130
 Why?
Epitopes
1
2018
479
0.130
 Why?
Cholangiopancreatography, Magnetic Resonance
1
2016
24
0.130
 Why?
Hyperglycemia
1
2020
347
0.130
 Why?
Triiodobenzoic Acids
1
2016
9
0.130
 Why?
Organ Preservation Solutions
3
2005
45
0.120
 Why?
Cholangitis, Sclerosing
1
2016
75
0.120
 Why?
Radiographic Image Enhancement
1
2016
58
0.120
 Why?
Sex Factors
1
2022
2071
0.120
 Why?
Printing, Three-Dimensional
1
2016
95
0.120
 Why?
Bacteriocins
1
2015
3
0.120
 Why?
Embolization, Therapeutic
1
2018
229
0.120
 Why?
Cannabis
1
2023
494
0.120
 Why?
Hepatitis B
1
2016
70
0.120
 Why?
Genes, BRCA2
1
2015
31
0.120
 Why?
Recovery of Function
1
2019
653
0.120
 Why?
Machine Learning
1
2020
493
0.120
 Why?
Genes, BRCA1
1
2015
40
0.120
 Why?
Pneumonia, Viral
1
2020
373
0.120
 Why?
Coronavirus Infections
1
2020
364
0.120
 Why?
Interferon-gamma
1
2018
789
0.120
 Why?
Organ Preservation
3
2004
102
0.120
 Why?
Papilloma, Intraductal
1
2014
3
0.110
 Why?
Heredity
1
2014
13
0.110
 Why?
Diabetes Mellitus, Type 1
10
2010
3715
0.110
 Why?
Membrane Proteins
1
2021
1164
0.110
 Why?
Germany
2
2024
121
0.110
 Why?
Genomics
2
2017
795
0.110
 Why?
Amylases
1
2013
17
0.110
 Why?
Risk Adjustment
1
2014
78
0.110
 Why?
Neoplasm, Residual
1
2014
133
0.110
 Why?
Tissue and Organ Harvesting
5
2005
70
0.110
 Why?
Apoptosis
6
2021
2553
0.110
 Why?
Reproducibility of Results
6
2019
3284
0.100
 Why?
High-Throughput Nucleotide Sequencing
1
2017
539
0.100
 Why?
Virus Diseases
1
2016
212
0.100
 Why?
Perception
1
2016
359
0.100
 Why?
Antibodies, Monoclonal
4
2005
1430
0.100
 Why?
Severity of Illness Index
3
2019
2828
0.100
 Why?
North America
2
2024
313
0.100
 Why?
Abdomen
2
2004
125
0.100
 Why?
MicroRNAs
2
2010
692
0.100
 Why?
Tacrolimus
2
2005
199
0.100
 Why?
Syndrome
1
2014
358
0.100
 Why?
Cell Proliferation
5
2021
2475
0.100
 Why?
Precision Medicine
1
2017
429
0.100
 Why?
Breast Neoplasms
2
2024
2253
0.100
 Why?
Cystadenoma, Mucinous
1
2013
13
0.100
 Why?
Cadaver
8
2005
296
0.100
 Why?
Diagnostic Imaging
1
2015
332
0.100
 Why?
Diagnostic Errors
1
2014
170
0.100
 Why?
Imaging, Three-Dimensional
1
2016
580
0.100
 Why?
ROC Curve
3
2024
554
0.100
 Why?
Insulin-Secreting Cells
2
2007
377
0.100
 Why?
Immunotherapy, Adoptive
1
2016
327
0.090
 Why?
Catheter Ablation
1
2015
350
0.090
 Why?
Neoplasms
2
2022
2671
0.090
 Why?
Endoscopy
1
2014
318
0.090
 Why?
Receptors, Antigen, T-Cell
1
2016
718
0.090
 Why?
Preoperative Care
1
2014
362
0.090
 Why?
C-Reactive Protein
1
2013
410
0.090
 Why?
Loss of Heterozygosity
1
2011
51
0.090
 Why?
Carcinoma in Situ
1
2011
49
0.090
 Why?
Biomarkers
1
2022
4149
0.090
 Why?
Kruppel-Like Transcription Factors
1
2011
66
0.090
 Why?
Raffinose
3
2005
23
0.080
 Why?
Graft Rejection
5
2005
624
0.080
 Why?
Disaccharides
3
2005
19
0.080
 Why?
Glucose
3
2020
1020
0.080
 Why?
Mannitol
3
2005
38
0.080
 Why?
Allopurinol
3
2005
63
0.080
 Why?
Glutamates
3
2005
59
0.080
 Why?
Histidine
3
2005
64
0.080
 Why?
United States
3
2024
14841
0.080
 Why?
Tissue and Organ Procurement
2
2004
321
0.080
 Why?
Electrolytes
3
2005
58
0.080
 Why?
Lung Neoplasms
1
2023
2526
0.080
 Why?
Duodenum
1
2010
78
0.080
 Why?
Lymph Nodes
2
2024
491
0.080
 Why?
CD8-Positive T-Lymphocytes
1
2016
900
0.080
 Why?
Quality of Health Care
1
2014
642
0.080
 Why?
Peptides
1
2015
985
0.080
 Why?
Cell Line, Tumor
4
2025
3412
0.080
 Why?
Tumor Cells, Cultured
2
2021
955
0.080
 Why?
Intra-Abdominal Fat
1
2009
91
0.070
 Why?
Down-Regulation
1
2011
657
0.070
 Why?
Adenosine
3
2005
225
0.070
 Why?
T-Lymphocytes, Regulatory
2
2022
385
0.070
 Why?
Glutathione
3
2005
356
0.070
 Why?
Magnetic Resonance Angiography
1
2010
240
0.070
 Why?
Enzyme Replacement Therapy
2
2018
15
0.070
 Why?
Germ-Line Mutation
2
2019
172
0.070
 Why?
Morbidity
2
2019
324
0.070
 Why?
ErbB Receptors
1
2010
614
0.070
 Why?
Gliclazide
1
2007
2
0.070
 Why?
Diabetic Retinopathy
2
2006
189
0.070
 Why?
Cytotoxicity, Immunologic
2
2018
224
0.070
 Why?
Clinical Decision-Making
2
2020
322
0.060
 Why?
Arterial Occlusive Diseases
1
2007
83
0.060
 Why?
Equilibrative Nucleoside Transporter 1
1
2006
17
0.060
 Why?
Extracorporeal Circulation
1
2006
13
0.060
 Why?
Blood Loss, Surgical
1
2007
101
0.060
 Why?
Consensus
2
2020
683
0.060
 Why?
Hepatectomy
2
2024
251
0.060
 Why?
C-Peptide
1
2007
163
0.060
 Why?
Child
4
2024
21935
0.060
 Why?
Hepatic Veins
1
2006
33
0.060
 Why?
Lacerations
1
2006
35
0.060
 Why?
Tumor Microenvironment
2
2020
674
0.060
 Why?
Vena Cava, Inferior
1
2006
71
0.060
 Why?
Neovascularization, Pathologic
1
2007
301
0.060
 Why?
Alcohol Drinking
2
2013
828
0.060
 Why?
Transplantation, Autologous
1
2006
238
0.060
 Why?
Drug Resistance, Neoplasm
1
2010
801
0.060
 Why?
Proto-Oncogene Proteins c-bcl-2
2
2007
233
0.060
 Why?
Chemotherapy, Cancer, Regional Perfusion
1
2024
28
0.060
 Why?
Abdominal Injuries
1
2006
123
0.060
 Why?
Jehovah's Witnesses
1
2004
3
0.060
 Why?
Bezoars
1
2004
4
0.060
 Why?
Smoking
2
2013
1627
0.050
 Why?
Contrast Media
3
2016
467
0.050
 Why?
Anthropometry
1
2024
213
0.050
 Why?
Splenectomy
1
2024
62
0.050
 Why?
Biopsy
3
2019
1129
0.050
 Why?
Intestinal Obstruction
1
2004
51
0.050
 Why?
Consensus Development Conferences as Topic
1
2023
31
0.050
 Why?
Chemotaxis
1
2004
131
0.050
 Why?
Cystectomy
1
2003
37
0.050
 Why?
RNA, Messenger
5
2011
2833
0.050
 Why?
Antioxidants
1
2007
584
0.050
 Why?
Intestine, Small
1
2004
156
0.050
 Why?
Postoperative Period
2
2019
342
0.050
 Why?
Health Care Surveys
1
2025
565
0.050
 Why?
Ileum
1
2003
119
0.050
 Why?
Intraoperative Complications
1
2004
138
0.050
 Why?
Wounds, Nonpenetrating
1
2006
278
0.050
 Why?
Propylamines
1
2022
10
0.050
 Why?
Delphi Technique
1
2024
280
0.050
 Why?
Gastrectomy
1
2023
126
0.050
 Why?
Carbohydrates
1
2022
65
0.050
 Why?
Stents
2
2022
527
0.050
 Why?
Genetic Testing
1
2005
460
0.050
 Why?
Azathioprine
1
2001
54
0.050
 Why?
Urinary Bladder
1
2003
183
0.050
 Why?
Creatinine
4
2004
499
0.040
 Why?
Vascular Diseases
1
2004
243
0.040
 Why?
Reverse Transcriptase Polymerase Chain Reaction
3
2011
976
0.040
 Why?
Mycophenolic Acid
1
2001
117
0.040
 Why?
Retroperitoneal Space
3
2005
20
0.040
 Why?
Hernia, Inguinal
1
2001
36
0.040
 Why?
Necrosis
1
2022
246
0.040
 Why?
Ephrin-B2
1
2021
47
0.040
 Why?
Steroids
1
2001
167
0.040
 Why?
Endometriosis
1
2001
51
0.040
 Why?
Hyperplasia
1
2021
175
0.040
 Why?
Endoscopy, Gastrointestinal
1
2023
228
0.040
 Why?
Urinary Bladder Neoplasms
1
2003
252
0.040
 Why?
Microbial Viability
1
2021
91
0.040
 Why?
Case-Control Studies
2
2022
3556
0.040
 Why?
Medical Oncology
1
2022
289
0.040
 Why?
Diagnosis, Computer-Assisted
1
2020
89
0.040
 Why?
Capecitabine
1
2019
45
0.040
 Why?
Adipose Tissue
1
2024
635
0.040
 Why?
Secretin
2
2010
6
0.040
 Why?
Mice, Inbred C57BL
2
2021
5757
0.040
 Why?
Matched-Pair Analysis
1
2019
39
0.040
 Why?
Florida
1
2020
107
0.040
 Why?
Republic of Korea
1
2019
37
0.040
 Why?
Margins of Excision
1
2019
50
0.040
 Why?
Mice
3
2022
17787
0.040
 Why?
Hematopoietic Stem Cell Transplantation
1
2005
622
0.040
 Why?
Asia
1
2019
71
0.040
 Why?
Treatment Failure
3
2005
356
0.040
 Why?
International Cooperation
1
2020
198
0.040
 Why?
Cell Death
1
2021
374
0.040
 Why?
Area Under Curve
1
2019
314
0.040
 Why?
Acute Disease
1
2022
1007
0.040
 Why?
Aquaporin 1
1
2018
3
0.040
 Why?
Hyperthermia, Induced
1
2020
116
0.040
 Why?
Cells, Cultured
3
2016
4193
0.040
 Why?
Radiotherapy
1
2019
201
0.040
 Why?
Mice, Nude
1
2020
698
0.040
 Why?
Stromal Cells
1
2019
112
0.040
 Why?
Pancreatic Elastase
1
2018
58
0.040
 Why?
Cause of Death
3
2005
434
0.040
 Why?
Congresses as Topic
1
2020
233
0.040
 Why?
Anastomosis, Roux-en-Y
2
2010
28
0.040
 Why?
Hospitals, High-Volume
1
2018
44
0.040
 Why?
Multivariate Analysis
2
2013
1509
0.040
 Why?
Xenograft Model Antitumor Assays
1
2021
872
0.030
 Why?
Preoperative Period
1
2018
129
0.030
 Why?
Anastomotic Leak
1
2017
41
0.030
 Why?
Betacoronavirus
1
2020
270
0.030
 Why?
Tumor Suppressor Protein p53
2
2017
528
0.030
 Why?
Oligonucleotide Array Sequence Analysis
2
2010
767
0.030
 Why?
Robotic Surgical Procedures
1
2019
130
0.030
 Why?
Patient Safety
1
2020
314
0.030
 Why?
Intestinal Neoplasms
1
2016
29
0.030
 Why?
Diabetic Nephropathies
3
2005
294
0.030
 Why?
Cell Movement
1
2021
967
0.030
 Why?
Drug Therapy, Combination
3
2004
1066
0.030
 Why?
Principal Component Analysis
1
2016
195
0.030
 Why?
Proto-Oncogene Proteins p21(ras)
1
2017
267
0.030
 Why?
Transplantation, Homologous
2
2010
416
0.030
 Why?
Mass Spectrometry
1
2019
739
0.030
 Why?
Anastomosis, Surgical
1
2016
153
0.030
 Why?
Nutritional Status
1
2018
350
0.030
 Why?
Vitamins
1
2017
185
0.030
 Why?
Radiographic Image Interpretation, Computer-Assisted
1
2016
110
0.030
 Why?
Feces
1
2018
484
0.030
 Why?
Cell Line
1
2021
2847
0.030
 Why?
Research Design
1
2021
1139
0.030
 Why?
Anatomy, Cross-Sectional
1
2014
10
0.030
 Why?
Extracellular Matrix
1
2019
528
0.030
 Why?
Flow Cytometry
1
2018
1178
0.030
 Why?
Animals
3
2022
36940
0.030
 Why?
Radiation Dosage
1
2016
179
0.030
 Why?
Intraoperative Care
1
2014
52
0.030
 Why?
Kidney Failure, Chronic
3
2004
570
0.030
 Why?
Systemic Inflammatory Response Syndrome
1
2014
93
0.030
 Why?
Immunologic Memory
1
2016
353
0.030
 Why?
Indole Alkaloids
1
2013
7
0.030
 Why?
Dose-Response Relationship, Drug
2
2010
2057
0.030
 Why?
Feasibility Studies
1
2017
956
0.030
 Why?
Antigens, Neoplasm
1
2016
319
0.030
 Why?
Drug Administration Schedule
2
2005
786
0.030
 Why?
Biomedical Research
1
2019
692
0.030
 Why?
Drug Interactions
2
2005
410
0.030
 Why?
Cytokines
2
2016
2085
0.030
 Why?
Peptic Ulcer
1
2013
20
0.030
 Why?
Algorithms
1
2020
1704
0.020
 Why?
Histocompatibility Testing
2
2004
126
0.020
 Why?
Asymptomatic Diseases
1
2013
89
0.020
 Why?
Safety
2
2004
338
0.020
 Why?
Postoperative Care
1
2013
261
0.020
 Why?
Global Health
1
2015
386
0.020
 Why?
Lymphocyte Activation
1
2016
1142
0.020
 Why?
Hypoxia
1
2019
1112
0.020
 Why?
Pandemics
1
2020
1639
0.020
 Why?
Randomized Controlled Trials as Topic
1
2017
1477
0.020
 Why?
Carcinoma, Renal Cell
1
2013
217
0.020
 Why?
Korea
1
2010
16
0.020
 Why?
In Situ Hybridization
1
2011
316
0.020
 Why?
Anti-Bacterial Agents
1
2021
1809
0.020
 Why?
Cell Growth Processes
1
2010
52
0.020
 Why?
Matrix Metalloproteinase 2
1
2010
56
0.020
 Why?
Microsatellite Repeats
1
2011
168
0.020
 Why?
Odds Ratio
1
2013
1070
0.020
 Why?
Lung
1
2023
4060
0.020
 Why?
Biopsy, Needle
1
2010
189
0.020
 Why?
Matrix Metalloproteinase 9
1
2010
132
0.020
 Why?
Edetic Acid
1
2009
50
0.020
 Why?
Pyridoxal Phosphate
1
2009
24
0.020
 Why?
Cardiovascular Diseases
1
2001
2111
0.020
 Why?
Blood Glucose
3
2004
2186
0.020
 Why?
Thyroid Neoplasms
1
2013
343
0.020
 Why?
PTEN Phosphohydrolase
1
2010
167
0.020
 Why?
Tetrazolium Salts
1
2008
17
0.020
 Why?
Kidney Neoplasms
1
2013
403
0.020
 Why?
Thiazoles
1
2008
123
0.020
 Why?
Proto-Oncogene Proteins c-akt
1
2010
437
0.020
 Why?
Vascular Endothelial Growth Factor A
1
2010
545
0.020
 Why?
bcl-2-Associated X Protein
1
2007
56
0.020
 Why?
Glyburide
1
2007
32
0.020
 Why?
Surgical Procedures, Operative
1
2010
259
0.020
 Why?
Recurrence
1
2010
1060
0.020
 Why?
Epigenesis, Genetic
1
2011
660
0.020
 Why?
Deoxycytidine Kinase
1
2006
3
0.020
 Why?
Ribonucleoside Diphosphate Reductase
1
2006
6
0.020
 Why?
Microscopy, Electron
1
2007
443
0.020
 Why?
Motorcycles
1
2006
7
0.020
 Why?
Choledochostomy
1
2006
11
0.020
 Why?
Budd-Chiari Syndrome
1
2006
5
0.020
 Why?
Tyrosine
1
2007
222
0.020
 Why?
5'-Nucleotidase
1
2006
41
0.020
 Why?
Mutation
1
2017
3958
0.020
 Why?
Cytidine Deaminase
1
2006
61
0.020
 Why?
Fluorescein Angiography
1
2006
151
0.020
 Why?
Phosphorylation
1
2010
1759
0.010
 Why?
Economics, Pharmaceutical
1
2005
9
0.010
 Why?
Antilymphocyte Serum
1
2005
66
0.010
 Why?
Prostatic Neoplasms
1
2013
1043
0.010
 Why?
Colorectal Neoplasms
1
2013
806
0.010
 Why?
Blood Group Incompatibility
1
2005
15
0.010
 Why?
Hemorrhage
1
2010
722
0.010
 Why?
Fatal Outcome
1
2006
303
0.010
 Why?
Methylprednisolone
1
2005
86
0.010
 Why?
Maximum Tolerated Dose
1
2005
199
0.010
 Why?
Isoantibodies
1
2005
60
0.010
 Why?
Proteomics
1
2011
1111
0.010
 Why?
Glycerolphosphate Dehydrogenase
1
2004
6
0.010
 Why?
Accidents, Traffic
1
2006
190
0.010
 Why?
Fructose-Bisphosphate Aldolase
1
2004
9
0.010
 Why?
Glucokinase
1
2004
15
0.010
 Why?
DNA Primers
1
2005
515
0.010
 Why?
Pyruvate Kinase
1
2004
29
0.010
 Why?
Intraocular Pressure
1
2006
307
0.010
 Why?
Renal Circulation
1
2004
58
0.010
 Why?
Visual Acuity
1
2006
356
0.010
 Why?
Diabetic Neuropathies
1
2005
94
0.010
 Why?
Tissue Culture Techniques
1
2004
78
0.010
 Why?
Transcriptional Activation
1
2006
378
0.010
 Why?
Pharmacogenetics
1
2005
180
0.010
 Why?
Tumor Suppressor Proteins
1
2006
327
0.010
 Why?
Kidney Function Tests
1
2003
160
0.010
 Why?
Monitoring, Physiologic
1
2005
275
0.010
 Why?
Carcinoma, Transitional Cell
1
2003
71
0.010
 Why?
Cell Separation
1
2004
318
0.010
 Why?
Respiratory Insufficiency
1
2006
318
0.010
 Why?
In Vitro Techniques
1
2004
1092
0.010
 Why?
Base Sequence
1
2005
2181
0.010
 Why?
Thrombosis
1
2005
371
0.010
 Why?
Vulvar Diseases
1
2001
9
0.010
 Why?
Obesity, Morbid
1
2005
264
0.010
 Why?
Immunoenzyme Techniques
1
2001
219
0.010
 Why?
Gene Expression
1
2006
1502
0.010
 Why?
Ischemia
1
2004
409
0.010
 Why?
Glucocorticoids
1
2005
594
0.010
 Why?
Morphogenesis
1
2001
166
0.010
 Why?
Hemodynamics
1
2004
1113
0.010
 Why?
Neoplasm Proteins
1
2001
434
0.010
 Why?
Blood Pressure
1
2005
1786
0.010
 Why?
T-Lymphocytes
1
2005
1996
0.010
 Why?
Hypoglycemic Agents
1
2005
1291
0.010
 Why?
Body Mass Index
1
2004
2389
0.010
 Why?
Infant, Newborn
1
2001
6079
0.000
 Why?
Del Chiaro's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (577) concept(s)
_
Co-Authors Expand Description
See all (52) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)